Chemical Component Summary

Name6-(2-chloranyl-6-methyl-pyridin-4-yl)-5-(4-fluorophenyl)-1,2,4-triazin-3-amine
Identifiers6-(2-chloranyl-6-methyl-pyridin-4-yl)-5-(4-fluorophenyl)-1,2,4-triazin-3-amine
FormulaC15 H11 Cl F N5
Molecular Weight315.733
TypeNON-POLYMER
Isomeric SMILESCc1cc(cc(n1)Cl)c2c(nc(nn2)N)c3ccc(cc3)F
InChIInChI=1S/C15H11ClFN5/c1-8-6-10(7-12(16)19-8)14-13(20-15(18)22-21-14)9-2-4-11(17)5-3-9/h2-7H,1H3,(H2,18,20,22)
InChIKeyNCWQLHHDGDXIJN-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count33
Chiral Atom Count0
Bond Count35
Aromatic Bond Count18

Drug Info: DrugBank

DrugBank IDDB16192 
NameImaradenant
Groups investigational
DescriptionImaradenant is under investigation in clinical trial NCT03381274 (Oleclumab (MEDI9447) Egfrm NSCLC Novel Combination Study).
SynonymsImaradenant
CAS number1321514-06-0

Related Resource References

Resource NameReference
PubChem 86676119